Annual EBIT
-$10.07 M
-$27.55 M-157.64%
31 December 2023
Summary:
InterCure annual earnings before interest & taxes is currently -$10.07 million, with the most recent change of -$27.55 million (-157.64%) on 31 December 2023. During the last 3 years, it has risen by +$925.70 thousand (+8.42%). INCR annual EBIT is now -157.64% below its all-time high of $20.97 million.INCR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
N/A
01 June 2024
Summary:
InterCure quarterly earnings before interest & taxes is not available.INCR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
N/A
01 June 2024
Summary:
InterCure TTM earnings before interest & taxes is not available.INCR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INCR EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -157.6% | - | - |
| 3 y3 years | +8.4% | - | - |
| 5 y5 years | -207.2% | - | - |
INCR EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -157.6% | +8.4% | ||||
| 5 y | 5 years | -157.6% | +8.4% | ||||
| alltime | all time | -157.6% | +8.4% |
InterCure EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$10.07 M(-157.6%) | - | - |
| June 2023 | - | $1.79 M(-15.5%) | $7.43 M(-43.4%) |
| Mar 2023 | - | $2.12 M(-263.3%) | $13.13 M(-26.2%) |
| Dec 2022 | $17.48 M(+137.3%) | -$1.30 M(-127.0%) | $17.80 M(-13.5%) |
| Sept 2022 | - | $4.82 M(-35.7%) | $20.58 M(+19.9%) |
| June 2022 | - | $7.49 M(+10.3%) | $17.16 M(+40.1%) |
| Mar 2022 | - | $6.79 M(+361.2%) | $12.25 M(+70.0%) |
| Dec 2021 | $7.36 M(-167.0%) | $1.47 M(+4.8%) | $7.21 M(-247.4%) |
| Sept 2021 | - | $1.41 M(-45.6%) | -$4.89 M(-7.6%) |
| June 2021 | - | $2.58 M(+47.8%) | -$5.29 M(-34.9%) |
| Mar 2021 | - | $1.75 M(-116.4%) | -$8.13 M(-27.9%) |
| Dec 2020 | -$11.00 M(+752.5%) | -$10.63 M(-1160.4%) | -$11.29 M(+96.6%) |
| Sept 2020 | - | $1.00 M(-494.3%) | -$5.74 M(-46.8%) |
| June 2020 | - | -$254.20 K(-81.9%) | -$10.79 M(-19.5%) |
| Mar 2020 | - | -$1.41 M(-72.3%) | -$13.40 M(+731.5%) |
| Dec 2019 | -$1.29 M(-60.7%) | - | - |
| Dec 2019 | - | -$5.08 M(+25.7%) | -$1.61 M(-146.4%) |
| Sept 2019 | - | -$4.04 M(+41.2%) | $3.47 M(-53.8%) |
| June 2019 | - | -$2.86 M(-127.6%) | $7.51 M(-27.6%) |
| Mar 2019 | - | $10.38 M(-7005.5%) | $10.38 M(+6419.4%) |
| Dec 2018 | -$3.28 M(+142.4%) | - | - |
| Dec 2017 | -$1.35 M(-907.4%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $167.50 K(-134.6%) | -$150.30 K(-235.8%) | $159.20 K(+552.5%) |
| Sept 2016 | - | $110.70 K(-171.0%) | $24.40 K(-108.8%) |
| June 2016 | - | -$155.90 K(-144.0%) | -$278.80 K(+340.4%) |
| Mar 2016 | - | $354.70 K(-224.4%) | -$63.30 K(-84.2%) |
| Dec 2015 | -$484.10 K(-54.5%) | -$285.10 K(+48.1%) | -$399.90 K(+33.8%) |
| Sept 2015 | - | -$192.50 K(-423.0%) | -$298.90 K(-41.4%) |
| June 2015 | - | $59.60 K(+229.3%) | -$510.50 K(-41.8%) |
| Mar 2015 | - | $18.10 K(-109.8%) | -$877.70 K(-15.5%) |
| Dec 2014 | -$1.06 M(-41.2%) | -$184.10 K(-54.4%) | -$1.04 M(-21.2%) |
| Sept 2014 | - | -$404.10 K(+31.4%) | -$1.32 M(-14.3%) |
| June 2014 | - | -$307.60 K(+114.4%) | -$1.54 M(-6.7%) |
| Mar 2014 | - | -$143.50 K(-69.0%) | -$1.65 M(-9.9%) |
| Dec 2013 | -$1.81 M(-115.4%) | -$463.50 K(-25.8%) | -$1.83 M(-49.3%) |
| Sept 2013 | - | -$624.60 K(+49.5%) | -$3.61 M(-136.0%) |
| June 2013 | - | -$417.90 K(+28.7%) | $10.04 M(-9.4%) |
| Mar 2013 | - | -$324.80 K(-85.5%) | $11.08 M(-2.2%) |
| Dec 2012 | $11.77 M(>+9900.0%) | -$2.24 M(-117.2%) | $11.33 M(-16.5%) |
| Sept 2012 | - | $13.03 M(+1998.4%) | $13.57 M(+2408.3%) |
| June 2012 | - | $621.00 K(-877.2%) | $541.10 K(-777.2%) |
| Mar 2012 | - | -$79.90 K | -$79.90 K |
| Dec 2011 | $89.60 K(-109.0%) | - | - |
| Dec 2010 | -$993.20 K | - | - |
FAQ
- What is InterCure annual earnings before interest & taxes?
- What is the all time high annual EBIT for InterCure?
- What is InterCure annual EBIT year-on-year change?
- What is the all time high quarterly EBIT for InterCure?
- What is the all time high TTM EBIT for InterCure?
What is InterCure annual earnings before interest & taxes?
The current annual EBIT of INCR is -$10.07 M
What is the all time high annual EBIT for InterCure?
InterCure all-time high annual earnings before interest & taxes is $20.97 M
What is InterCure annual EBIT year-on-year change?
Over the past year, INCR annual earnings before interest & taxes has changed by -$27.55 M (-157.64%)
What is the all time high quarterly EBIT for InterCure?
InterCure all-time high quarterly earnings before interest & taxes is $13.03 M
What is the all time high TTM EBIT for InterCure?
InterCure all-time high TTM earnings before interest & taxes is $20.58 M